Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Chelala

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Investigation|May 5, 2009
CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cellsYaohe Wang, Rathi Gangeswaran, Xingbo Zhao, et al.
The Journal of Clinical Investigation|October 27, 2020
mTOR-dependent translation amplifies microglia priming in aging miceLily Keane, Ignazio Antignano, Sean-Patrick Riechers, et al.
The Journal of Clinical Investigation|October 15, 2021
mTOR-dependent translation amplifies microglia priming in aging miceLily Keane, Ignazio Antignano, Sean-Patrick Riechers, et al.
Leukemia|March 24, 2018
Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphomaShamzah Araf, Jun Wang, Koorosh Korfi, et al.
Leukemia|March 24, 2019
Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphomaShamzah Araf, Jun Wang, Koorosh Korfi, et al.
Cell Reports|June 4, 2026
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven CancerAbbie E Fearon, Edward P Carter, Natasha S Clayton, et al.
Cell Reports|March 1, 2018
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven CancerAbbie E Fearon, Edward P Carter, Natasha S Clayton, et al.
BMC Proceedings|April 2, 2026
Multimodal AI-driven analysis in breast and lung cancer: insights from the OPTIMA prototyping workshopMaryam Abdollahyan, Emanuela Gadaleta, Lewis G E James, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2019
A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic CancerShuangshuang Lu, Zhe Zhang, Pan Du, et al.
The Journal of Pathology|July 2, 2019
The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapyClaire S Reader, Sabari Vallath, Colin W Steele, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Investigation|May 5, 2009
CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cellsYaohe Wang, Rathi Gangeswaran, Xingbo Zhao, et al.
The Journal of Clinical Investigation|October 27, 2020
mTOR-dependent translation amplifies microglia priming in aging miceLily Keane, Ignazio Antignano, Sean-Patrick Riechers, et al.
The Journal of Clinical Investigation|October 15, 2021
mTOR-dependent translation amplifies microglia priming in aging miceLily Keane, Ignazio Antignano, Sean-Patrick Riechers, et al.
Leukemia|March 24, 2018
Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphomaShamzah Araf, Jun Wang, Koorosh Korfi, et al.
Leukemia|March 24, 2019
Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphomaShamzah Araf, Jun Wang, Koorosh Korfi, et al.
Cell Reports|June 4, 2026
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven CancerAbbie E Fearon, Edward P Carter, Natasha S Clayton, et al.
Cell Reports|March 1, 2018
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven CancerAbbie E Fearon, Edward P Carter, Natasha S Clayton, et al.
BMC Proceedings|April 2, 2026
Multimodal AI-driven analysis in breast and lung cancer: insights from the OPTIMA prototyping workshopMaryam Abdollahyan, Emanuela Gadaleta, Lewis G E James, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2019
A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic CancerShuangshuang Lu, Zhe Zhang, Pan Du, et al.
The Journal of Pathology|July 2, 2019
The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapyClaire S Reader, Sabari Vallath, Colin W Steele, et al.
Pageof 12